Drug Profile
DAB389 gastrin-releasing peptide
Alternative Names: DAB389gastrin-releasing peptide; DAB389GRPLatest Information Update: 23 Feb 2000
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Peptides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 23 Feb 2000 No-Development-Reported for Cancer in USA (Unknown route)
- 25 Feb 1997 New profile
- 25 Feb 1997 Preclinical development for Cancer in USA (Unknown route)